Titan Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-0.580.29
Price/Sales ratio
7.111.41
Earnings per Share (EPS)
$-8.6$17.4

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-360.78-157.87323.07-39.41-16.64-0.00-0.59-1.22-1.02-1.11-0.00-16.64
Price/Sales ratio
237.781.06K110.122.62K25.400.042.566.50174.6433.710.030.04
Price/Book Value ratio
100.68254.74125.76658.0021.980.103.511.937.680.930.000.10
Price/Cash Flow ratio
-147.82-238.50263.62-43.25-17.81-0.00-0.72-1.25-1.28-0.87-0.00-17.81
Price/Free Cash Flow ratio
-147.36-234.33270.99-42.67-16.97-0.00-0.69-1.25-1.28-0.87-0.00-16.97
Price/Earnings Growth ratio
2.96-0.52-2.240.100.27N/A0.000.010.110.02-0.06N/A
Dividend Yield
N/AN/AN/AN/A0.18%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-11.76%-179.77%59.33%-4387.44%90.89%64.33%90.24%86.95%-226.66%-939.67%99.84%90.89%
Operating Profit Margin
-95.30%-404.48%28.82%-6745.11%-139.80%-466.46%-151.94%-612.97%-17058.33%-3954.89%-2202.14%-466.46%
Pretax Profit Margin
-65.90%-674.98%34.08%-6654.41%-152.64%-455.77%-153.10%-575.09%-17010%-3026.63%-2206.75%-455.77%
Net Profit Margin
-65.90%-674.98%34.08%-6654.41%-152.64%-445.55%-428.44%-531.71%-16961.66%-3026.63%-2206.75%-445.55%
Effective Tax Rate
44.61%-40.07%-15.42%1.74%18.24%2.24%-179.84%7.54%0.28%N/AN/A2.24%
Return on Assets
-11.52%-84.88%27.50%-160.66%-64.01%-168.96%-256.31%-101.50%-250.78%-68.87%-188.45%-168.96%
Return On Equity
-27.90%-161.35%38.92%-1669.42%-132.08%-1122.74%-586.86%-157.92%-746.66%-83.84%-165.69%-1122.74%
Return on Capital Employed
-24.49%-80.13%31.44%-326.54%-77.64%-284.43%-190.24%-175.66%-716.73%-109.56%-534.42%-284.43%
Liquidity Ratios
Current Ratio
2.932.523.671.863.852.301.73N/AN/AN/A1.362.30
Quick Ratio
2.932.523.671.863.482.031.652.591.325.551.132.03
Cash ratio
2.321.612.881.682.691.451.282.261.114.681.111.45
Days of Sales Outstanding
397.23920.2586.90110.34113.3744.2766.6926.782192.07K37.9144.27
Days of Inventory outstanding
0.000.000.00N/A856.18282.81253.64537.41197.39N/AN/A282.81
Operating Cycle
397.23920.2586.90110.34969.56327.09320.33564.20416.392.07KN/A327.09
Days of Payables Outstanding
394.82324.63179.6431.051.03K230.95968.951.45K1.29K66.39N/A230.95
Cash Conversion Cycle
2.40595.61-92.7379.28-65.7396.13-648.61-893.96-877.862.00KN/A-65.73
Debt Ratios
Debt Ratio
N/AN/AN/A0.730.300.450.100.010.030.060.660.30
Debt Equity Ratio
N/AN/AN/A7.680.632.990.220.020.080.071.970.63
Long-term Debt to Capitalization
N/AN/AN/A0.800.350.730.08N/AN/AN/A0.040.73
Total Debt to Capitalization
N/AN/AN/A0.880.380.740.180.020.080.070.120.74
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-9.55N/AN/AN/A-293.52N/A
Cash Flow to Debt Ratio
N/AN/AN/A-1.98-1.95-3.59-21.26-70.52-67.07-14.18-69.05-3.59
Company Equity Multiplier
2.421.901.4110.392.066.642.281.552.971.212.972.06
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-1.60-4.460.41-60.64-1.42-4.27-3.55-5.17-136.38-38.54-37.26-4.27
Free Cash Flow / Operating Cash Flow Ratio
1.001.010.971.011.041.011.031.0011.0011.01
Cash Flow Coverage Ratio
N/AN/AN/A-1.98-1.95-3.59-21.26-70.52-67.07-14.18-69.05-3.59
Short Term Coverage Ratio
N/AN/AN/A-4.34-15.99-56.78-36.06-70.52-67.07-14.18-105.85-56.78
Dividend Payout Ratio
N/AN/AN/AN/A-3.15%N/AN/AN/AN/AN/AN/A-3.15%